ImmunoGenesis, Inc.

Biotechnology company · Doylestown, Pennsylvania, United States

ImmunoGenesis, Inc. is a biotechnology company headquartered in Doylestown, Pennsylvania, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $5.7 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

ImmunoGenesis at a glance

Typebiotechnology company

HeadquartersDoylestown, Pennsylvania, United States

Earliest incorporation on record2019

SEC CIK2018057

What does ImmunoGenesis do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $5.7 million sold (2025).

Frequently asked questions about ImmunoGenesis

Where is ImmunoGenesis headquartered?

ImmunoGenesis, Inc. is headquartered in Doylestown, Pennsylvania, United States.

What does ImmunoGenesis do?

ImmunoGenesis, Inc. is a biotechnology company.

When was ImmunoGenesis founded?

The earliest incorporation on record for ImmunoGenesis, Inc. is in 2019, according to public company registers.

Similar companies

ImCare Biotech, Inc.Doylestown, Pennsylvania, United States
Thrombolex, Inc.Doylestown, Pennsylvania, United States
Prolifagen, Inc.Doylestown, Pennsylvania, United States
IVIEW Therapeutics IncDoylestown, Pennsylvania, United States
Atrin Pharmaceuticals LLCDoylestown, Pennsylvania, United States
Fox Chase Chemical Diversity Center Inc.Doylestown, Pennsylvania, United States
Conifer Point Pharmaceuticals LLCDoylestown, Pennsylvania, United States
Chemia Biosciences, Inc.Doylestown, Pennsylvania, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences